PAS
IBB icon

Park Avenue Securities’s iShares Biotechnology ETF IBB Stock Holding History

Park Avenue Securities’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$953K Sell
5,013
-2,201
-31% -$378K 0.01% 977
2026
Q1 		$1.22M Buy
7,214
+705
+11% +$121K 0.01% 727
2025
Q4 		$1.1M Buy
+6,509
New +$1.06M 0.01% 767
2025
Q1 		– Sell
-1,524
Closed -$201K – 1335
2024
Q4 		$201K Buy
1,524
+30
+2% +$4.22K ﹤0.01% 1433
2024
Q3 		$218K Buy
+1,494
New +$216K ﹤0.01% 1315
2024
Q1 		– Sell
-1,772
Closed -$241K – 1385
2023
Q4 		$241K Sell
1,772
-172
-9% -$21K ﹤0.01% 1205
2023
Q3 		$238K Buy
+1,944
New +$247K ﹤0.01% 1151
2022
Q1 		– Sell
-6,769
Closed -$1.03M – 1149
2021
Q4 		$1.03M Buy
6,769
+653
+11% +$101K 0.02% 458
2021
Q3 		$989K Sell
6,116
-91
-1% -$15.3K 0.02% 415
2021
Q2 		$1.02M Sell
6,207
-3,747
-38% -$577K 0.02% 380
2021
Q1 		$1.5M Sell
9,954
-445
-4% -$70.7K 0.04% 252
2020
Q4 		$1.57M Sell
10,399
-510
-5% -$72.9K 0.04% 193
2020
Q3 		$1.48M Buy
10,909
+2,392
+28% +$325K 0.05% 170
2020
Q2 		$1.16M Buy
+8,517
New +$1.09M 0.04% 169
2020
Q1 		– Sell
-8,601
Closed -$1.04M – 421
2019
Q4 		$1.04M Buy
8,601
+4,418
+106% +$493K 0.04% 175
2019
Q3 		$416K Buy
+4,183
New +$438K 0.02% 286

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Park Avenue Securities's IBB Position: Q2 2026 in Review

Park Avenue Securities reduced its iShares Biotechnology ETF (IBB) stake by 31% in Q2 2026, selling an estimated $378K and leaving 5,013 shares worth $953K. The position accounts for 0.01% of the portfolio, ranked #977.

Park Avenue Securities first reported a position in IBB in Q3 2019 and has held it in 16 quarters since. The position peaked at $1.57M in Q4 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Park Avenue Securities held 5,013 shares of iShares Biotechnology ETF worth $953K as of Q2 2026.
  • Park Avenue Securities sold 2,201 iShares Biotechnology ETF shares in Q2 2026, an estimated $378K.
  • iShares Biotechnology ETF made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #977 holding.
  • Park Avenue Securities first reported a position in iShares Biotechnology ETF in Q3 2019 and has held it in 16 quarters since.
  • Park Avenue Securities's iShares Biotechnology ETF position peaked at $1.57M in Q4 2020.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.